Abiopharma

🔍 HOMBACH ROBERT J. (Director)

Company: Embecta Corp. (EMBC)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 45,000 shares of Common Stock at $4.9744 per share (Direct)
  Date: 2026-08-12 | Code: P | equity_swap_involved: 0 | shares_owned_after: 109,587.21 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in Column 4 is a weighted-average price. These shares were purchased in a series of transactions at prices ranging from $4.955 to $4.985, inclusive. The reporting person undertakes to provide to Embecta Corp., any security holder of Embecta Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• REMARKS: The Power of Attorney dated November 29, 2023 is incorporated herein by reference.